Heckel B (2024) Idiopathic intracranial hypertension after Abrupt Cessation of Medication: a Case Report of Abrupt Glucagon-Like Peptide-1 (GLP-1) receptor Agonist Cessation and Review of the literature
Sirtuin 3 is required for osteogenic differentiation through maintenance of PGC-1-SOD2-mediated regulation of mitochondrial function
Retatrutide is developed by Eli Lilly and Company, the same company that makes tirzepatide (Zepbound and Mounjaro)
Researchers studying pure angiogenesis, ECM remodeling, or cytoprotection without inflammatory confounders should choose GLOW
Key takeaways: GLP-1 medications are primarily used for weight loss, but are increasingly being explored in relation to PCOS and perimenopause Early evidence (mainly in women with obesity and PCOS) suggests GLP-1s may improve insulin resistance and support more regular menstrual cycles and ovulation There is currently limited research on how GLP-1 medications affect periods, fertility, PMS, or menopause symptoms in the wider population Period tracking apps like Clue may help users monitor cycle and symptom changes while using GLP-1 medications 1
Aetna will contact you or your healthcare provider with a coverage decision within 24 hours of receiving the request